Decorative. Mosaic of different medical pictures and illustrations.

Diagnostics and Disease Management Tools for Use in Underserved Populations: An NHLBI Research & Implementation Workshop

April 14 - 15, 2021
Virtual event


Underserved populations can include racial and ethnic minorities, immigrants, the homeless, low-income individuals, the uninsured and people who live in communities that are socioeconomically disadvantaged, rural or have few health care resources. People in these communities often face a complex set of challenges related to health and health care delivery. Not only can they face cultural, linguistic and financial barriers, but they also can be at higher risk for disease, face poorer health outcomes and have limited access to health care services.

On April 14-15, 2021, the NHLBI convened a virtual research event aimed at using technology to improve heart, lung blood and sleep health in historically underserved, low-resource and remote communities. During the two-day event, approximately 1,800 researchers, implementation scientists, technology and medical device experts, and community and federal health leaders came together to discuss potential sustainable and affordable technology solutions, effective community-based strategies and innovative models for disease management and diagnosis in underserved populations. The goal of the workshop was to identify potential technology barriers and solutions for disease diagnosis and management in these groups, highlight the ones that could have the greatest impact, and determine the ones best suited for further research.

On the first day, experts focused on recent research on diagnostic tools for heart, lung, blood and sleep disorders, implementation systems, and insights on applying these systems to improve health outcomes in underserved populations. On the second day, federal and community leaders shared successful stakeholder partnerships that could serve as models. They also discussed areas that needed improvement. In addition, speakers and participants discussed implementation challenges and collectively brainstormed ways to apply these advancements and innovations to heart, lung, blood and sleep conditions for underserved populations.


Watch the NIH Videocast:

Speakers, Panelists, and Moderators

  • Christopher Austin, M.D., National Center for Advancing Translational Sciences, NIH
  • Shauntice Allen, Ph.D., M.A., The University of Alabama at Birmingham
  • Jeroan Allison, M.D., M.S., University of Massachusetts Medical School
  • Elise Berliner, Ph.D., Agency for Healthcare Research and Quality
  • Lyle Best, M.D., Missouri Breaks Industries Research
  • Bishow Adhikari, Ph.D., Division of Cardiovascular Sciences (DCVS), NHLBI, NIH
  • Marishka Brown, Ph.D., National Center on Sleep Disorders Research, Division of Lung Diseases (DLD), NHLBI, NIH
  • Tyra Bryant-Stephens, M.D., Children's Hospital of Philadelphia
  • Olveen Carrasquillo, M.D., M.P.H., University of Miami Health System
  • Jue Chen, Ph.D., DCVS, NHLBI, NIH
  • Francis S. Collins, M.D., Ph.D., Director, NIH
  • Jean Marie Connors, M.D., Brigham and Women's Hospital and Harvard Medical School
  • Nakela L. Cook, M.D., M.P.H., Patient-Centered Outcomes Research Institute
  • M. Bradley Drummond, M.D., M.H.S., University of North Carolina at Chapel Hill
  • William England, Ph.D., JD, Health Resources and Services Administration
  • Chris Fore, Ph.D., Indian Health Service (IHS) TeleBehavioral Health Center of Excellence
  • Gary H. Gibbons, M.D., NHLBI, NIH
  • Umut Gurkan, Ph.D., Case Western Reserve University
  • David Harrison, M.D., Vanderbilt University
  • W. Keith Hoots, M.D., Division of Blood Diseases and Resources (DBDR), NHLBI, NIH
  • Monica Webb Hooper, Ph.D., National Institute on Minority Health and Health Disparities, NIH
  • Erin Iturriaga, DNP, M.S.N., RN, DCVS, NHLBI, NIH
  • Girardin Jean-Louis, Ph.D., NYU Langone Health, NYU Grossman School of Medicine
  • Tania Kamphaus, M.Sc., Ph.D., Foundation for the National Institutes of Health
  • Douglas Kelly, M.D., Center for Devices and Radiological Health, Food and Drug Administration (FDA)
  • Wilbur Lam, M.D., Ph.D., Emory University
  • Christine Lee, Ph.D., Pharm.D., Office of Minority Health and Health Equity, FDA
  • Meredith McCormack, M.D., M.H.S., Johns Hopkins University
  • David McManus, M.D., University of Massachusetts Medical School
  • Martin Mendoza, Ph.D., Office of Minority Health, HHS
  • Kyung Moon, Ph.D., DBDR, NHLBI, NIH
  • Mahasin Mujahid, Ph.D., M.S., FAHA, University of California, Berkeley
  • Wendy Nilsen, Ph.D., National Science Foundation
  • Patricia O'Brien-Richardson, Ph.D., Rutgers University
  • Marcia O'Leary, RN, Missouri Breaks Industries Research
  • Betty S. Pace, M.D., Augusta University
  • Athena Philis-Tsimikas, M.D., Scripps Research Translational Institute and the Scripps Whittier Diabetes Institute
  • Susy Postal, DNP, RN-BC, IHS
  • Naresh M. Punjabi, M.D., Ph.D., University of Miami
  • Kathleen Rousche, Ph.D., Office of Translational Alliances and Coordination (OTAC), NHLBI, NIH
  • Ŝeila Selimović, Ph.D., Biomedical Advanced Research and Development Authority
  • Michael Snyder, Ph.D, Stanford University
  • Leith States, M.D., M.P.H., Office of the Assistant Secretary for Health, HHS
  • Bruce J. Tromberg, Ph.D., National Institute of Biomedical Imaging and Bioengineering, NIH
  • Louis Vuga, M.D., M.P.H., Ph.D., DLD, NHLBI, NIH
  • Hilary Wall, M.P.H., Centers for Disease Control and Prevention
  • Makeda Williams, Ph.D., M.P.H., Center for Translation Research and Implementation Science (CTRIS), NHLBI, NIH
  • LCDR Shondelle Wilson-Frederick, Ph.D., Center for Medicaid and CHIP Services, Centers for Medicare & Medicaid Services